UNSPSC 51343509: Tenofovir alafenamide fumarate

This classification denotes a reverse transcriptase inhibitor and purine antagonist 2C21H29N6O5P.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FWF6Q91TZO, chemically known as l-alanine, n-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester, (2e)-2-butenedioate (2:1), but more generally known as tenofovir alafenamide fumarate, which bears US NIH Compound Identifier 71301443.

Most nations, for tariff and trade purposes, schedule tenofovir alafenamide fumarate under HS 29335995 and SITC 51576. As of Q4 2014, TENOFOVIR ALAFENAMIDE FUMARATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CN1CNC2C1NCNC2N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3CCCCC3.C[C@H](CN1CNC2C1NCNC2N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3CCCCC3.C(=C/C(=O)O)\C(=O)O.

UNSPSC 51343509 Tenofovir alafenamide fumarate, a Commodity code, shows little relevant recent activity. The recent opportunities posted under this code—a completed pharmaceutical warehouse piggyback award from the Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida IFB for Naloxone and drug deactivation systems—are unrelated to the specific antiretroviral compound named in the code. State and local solicitations tagged with this UNSPSC appear to reflect broader pharmaceutical procurement activity rather than targeted sourcing of tenofovir alafenamide fumarate itself.

The source provides no evidence of direct state or local demand for tenofovir alafenamide fumarate as a named line item. Agencies appear to use higher-tier pharmaceutical codes or cooperative purchasing vehicles (such as MMCAP Infuse) to aggregate multiple drug products rather than posting competitive solicitations for this specific compound. Business development pursuit under this Commodity code is not supported by recent state and local contracting activity.